Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Mar 2023
USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...
Read Full News1.
Is Chemotherapy via Peripheral IV Access More Effective Than Central Lines for Testicular Cancer?
2.
Papillary thyroid cancer: New markers offer hope for tailored treatment
3.
Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type
4.
For treatment, the majority of cancer patients choose complementary therapies.
5.
Risk-Benefit Analysis of CAR-T Therapies for Myeloma is Muddy by Early Death Risk.
1.
Managing Acute Respiratory Failure in Hematological Malignancies
2.
Deterministic Reprogramming of Neutrophils within Tumors: A New Frontier in Cancer Research
3.
Exploring the Latest Treatments for Essential Thrombocythemia
4.
How HLH is Revolutionizing Healthcare
5.
Obesity is a major risk factor for cancer
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
2.
Current Scenario of Cancer- Q&A Session to Close the Gap
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
4.
Navigating the Complexities of Ph Negative ALL - Part XVI
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge